Today: 10 June 2026
Browse Category

NYSE:UNH 17 August 2025 - 29 October 2025

UnitedHealth Stock Rallies After Bold Strategy Overhaul – Is 2026 a Turning Point?

UnitedHealth Stock Rallies After Bold Strategy Overhaul – Is 2026 a Turning Point?

UnitedHealth reported Q3 revenue of $113.2 billion, up 12% year-over-year, and raised its 2025 adjusted EPS outlook to at least $16.25, above consensus. Shares traded near $360 on Oct. 29, about 30% below April’s peak. The company will shift more doctors to employment and exit lower-profit markets. Q3 medical-loss ratio was about 89.9%, and UnitedHealth remains under federal Medicare Advantage scrutiny.
29 October 2025
·
Stocks to Buy Today (Oct. 22, 2025): Top Picks as Markets Near Record Highs

Stocks to Buy Today (Oct. 22, 2025): Top Picks as Markets Near Record Highs

U.S. stock indexes hover near record highs after the Dow gained 0.5% Tuesday, while the Nasdaq slipped 0.2% on tech earnings misses. About 85% of S&P 500 companies have beaten forecasts, the highest rate in four years. AMD surged to record highs on AI chip deals, while Eli Lilly hit $935 on obesity drug demand. Netflix fell 6–7% pre-market after an earnings miss; Texas Instruments dropped nearly 9% on weak guidance.
22 October 2025
···········
Top 5 Stocks to Buy Now: October 22, 2025

Top 5 Stocks to Buy Now: October 22, 2025

AMD shares have surged 80% in 2025, hitting record highs near $240 on strong AI chip demand and new deals with OpenAI and Oracle; analysts now target $300. TSMC trades near $294 after a 45% rally, with Bank of America projecting $330 as AI chip demand soars. UnitedHealth rebounded to $364 after an early plunge, but remains 30% below January. BYD stock is down 30% from May highs despite strong overseas EV sales forecasts. Eli Lilly leads the U.S. obesity drug market, with Q1 sales of $6.1 billion
21 October 2025
····
UnitedHealth Stock Rallies to $364 – Will UNH’s 2025 Comeback Last or Fade?

UnitedHealth Stock Rallies to $364 – Will UNH’s 2025 Comeback Last or Fade?

UnitedHealth Group shares closed at $364.48 on Oct. 21, up 2.2% on the day but still down about 30% for 2025 after plunging from an April peak near $630. The company will report Q3 earnings Oct. 28, with analysts expecting a sharp profit drop after UnitedHealth cut its full-year outlook due to surging medical costs. CEO Andrew Witty resigned in May, replaced by Stephen Hemsley.
21 October 2025
·
Elevance Health Stock Soars on Massive Q3 Earnings Beat – What It Means for Investors

Elevance Health Stock Soars on Massive Q3 Earnings Beat – What It Means for Investors

Elevance Health reported Q3 2025 adjusted earnings of $6.03 per share, beating analyst estimates by over $1. Revenue reached $50.1 billion, up 12% year-over-year and ahead of forecasts. Shares jumped as much as 7% pre-market on Oct. 21 before settling near the prior close. The company reaffirmed its full-year outlook and kept costs slightly below expectations.
21 October 2025
····
UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

UnitedHealth Group closed near $372 on Oct. 8, up over 2%, but remains far below its April high of $630. The company reported $422.8 billion in trailing 12-month revenue and $21.3 billion net income. Analysts raised price targets after recent upgrades, but the stock faces pressure from rising medical costs and regulatory probes. Third-quarter results are due Oct. 28, with guidance cut to $14.65 per share.
8 October 2025
·
Global Business Weekend: Record Highs, AI Shake-ups, Oil Bears & Major Deals

Global Business Weekend: Record Highs, AI Shake-ups, Oil Bears & Major Deals

The Dow Jones Industrial Average hit a record intraday high, surpassing its December peak, as UnitedHealth shares jumped 9.5% after Berkshire Hathaway disclosed a stake. Nvidia’s market value reached $4 trillion. Apple announced an additional $100 billion investment in U.S. projects. Meta Platforms reorganized its AI teams and secured $29 billion in financing for data centers.
17 August 2025
·········
1 … 8 9 10

Stock Market Today

  • BIO-key Receives Nasdaq Notice for Delayed 10-Q Filing
    June 10, 2026, 5:45 PM EDT. BIO-key International, Inc. (OTC: BKYI) received a non-compliance notice from Nasdaq for failing to file its Quarterly Report on Form 10-Q for Q1 2026 on time as required by Nasdaq Listing Rule 5250(c)(1). Nasdaq's notification states the company's delay could affect its continued listing on the Nasdaq Capital Market pending a Hearing Panel determination. BIO-key specializes in biometric authentication and identity access management (IAM) technologies. The company serves over 40 million users with its cloud-hosted and on-premise PortalGuard IAM solution, supporting secure, multi-factor authentication options including passwordless methods. This regulatory development adds pressure on BIO-key to meet reporting requirements amid its efforts to secure market confidence.

Latest articles

Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Snap Inc. Targets Health Ad Dollars With New Snapchat Study as Pressure Builds

Snap Shares Drop Again With Tech Names Under Pressure

10 June 2026
Snap Inc. shares slid 4% to $5.38, extending a three-day losing streak and deepening doubts about its turnaround despite improved cash flow and cost cuts, as investors await CEO Evan Spiegel’s June 16 AWE keynote and weigh weak ad growth, falling eCPMs, and ongoing macro and regulatory risks.
Go toTop